Advertisement

Citation tools

Kusumoto, Shigeru et al "Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy." Blood 133.2 (2019): 137-146. Web. 23 Jan. 2019.